Search Results
Search for other papers by Laura Monteonofrio in
Google Scholar
PubMed
Search for other papers by Maria Cristina Florio in
Google Scholar
PubMed
Longitudinal Study Section, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA
Division of Cardiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Search for other papers by Majd AlGhatrif in
Google Scholar
PubMed
Search for other papers by Edward G Lakatta in
Google Scholar
PubMed
Division of Cardiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Search for other papers by Maurizio C Capogrossi in
Google Scholar
PubMed
Coronavirus disease 2019 (COVID-19) is a new infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is frequently characterized by a marked inflammatory response with severe pneumonia and respiratory failure associated with multiorgan involvement. Some risk factors predispose patients to develop a more severe infection and to an increased mortality; among them, advanced age and male gender have been identified as major and independent risk factors for COVID-19 poor outcome. The renin-angiotensin-aldosterone system (RAAS) is strictly involved in COVID-19 because angiotensin converting enzyme 2 (ACE2) is the host receptor for SARS-CoV-2 and also converts pro-inflammatory angiotensin (Ang) II into anti-inflammatory Ang(1–7). In this review, we have addressed the effect of aging and gender on RAAS with emphasis on ACE2, pro-inflammatory Ang II/Ang II receptor 1 axis and anti-inflammatory Ang(1–7)/Mas receptor axis.
